Ensysce Biosciences, Inc. (ENSC) vs Palatin Technologies, Inc. (PTN)

Ensysce Biosciences, Inc. and Palatin Technologies, Inc. are both Biotechnology companies. Ensysce Biosciences, Inc. and Palatin Technologies, Inc. are of similar size ($11.6M and $11.6M). Palatin Technologies, Inc. grew revenue faster over the last twelve months: 110.9% against −39.3%. Palatin Technologies, Inc. has the higher net margin (−63.5% vs −280.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Palatin Technologies, Inc. leads on 13 and Ensysce Biosciences, Inc. on 1.

Valuation

Metric ENSC PTN Biotechnology median
P/E n/m n/m 8.50
P/S 1.51 1.29 9.71
P/B n/m 2.55 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.54 0.73 9.21
Earnings yield (530.77%) (49.33%) (33.15%)
Free cash flow yield (130.64%) (79.85%) (25.50%)

Profitability

Metric ENSC PTN Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (281.32%) (65.74%) 0.00%
Net margin (280.49%) (63.54%) 0.00%
Free cash flow margin (196.76%) (103.07%) 0.00%
Return on equity (1,295.01%) (877.60%) (56.36%)
Return on assets (295.92%) (142.11%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ENSC PTN Biotechnology median
Revenue growth (TTM) (39.29%) 110.89% 6.02%
EPS growth (last fiscal year) 65.24% 90.79% 30.26%
Revenue growth, 5-year CAGR 5.21% 156.83% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENSC PTN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.70 4.61 4.72
Net debt to EBITDA 0.42 0.87 0.96

Dividend

Metric ENSC PTN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ENSC PTN Biotechnology median
Market cap 11.64m 11.55m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack